31.10 
0.08(0.26%) 11:19AM EDT - Nasdaq Real Time Price
| Prev Close: | 31.18 |
|---|
| Open: | 31.06 |
|---|
| Bid: | 31.18 x 200 |
|---|
| Ask: | 31.19 x 2800 |
|---|
| 1y Target Est: | 37.00 |
|---|
| Beta: | 1.032 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 30.84 - 31.24 |
|---|
| 52wk Range: | 30.42 - 35.42 |
|---|
| Volume: | 6,815,482 |
|---|
| Avg Vol (3m): | 3,711,660 |
|---|
| Market Cap: | 15.55B |
|---|
| P/E (ttm): | 33.53 |
|---|
| EPS (ttm): | 0.93 |
|---|
| Div & Yield: | 0.26 (0.80%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Pfizer holders should consider Zoetis exchange, says BMO Capitaltheflyonthewall.com(Wed 7:41AM EDT)
- [video] Time to Get Out of Stocks That Act Like Bonds?at CNBC(Wed 6:31AM EDT)
- Zoetis Exchange Offer Updateat Seeking Alpha(Tue, Jun 18)
- Your First Move for Wednesdayat CNBC(Tue, Jun 18)
- [video] FMHR Final Tradeat CNBC(Tue, Jun 18)
- Zoetis to Join S&P 500; First Horizon National, QLogic Moved to New Indicesat Motley Fool(Mon, Jun 17)
- Shorts Are Piling Into These Stocks. Should You Be Worried?at Motley Fool(Mon, Jun 17)
- Early Movers: SFD, NFLX, FB, CVX & Moreat CNBC(Mon, Jun 17)
- 3 Stock Picks for Pet Loversat Motley Fool(Sat, Jun 15)
- Pfizer For Zoetis: The Exchange, Market Mechanics & Analysisat Seeking Alpha(Sat, Jun 15)
- [$$] Shifting Windsat Barrons.com(Sat, Jun 15)
- Pfizer spin-off Zoetis to join S&P 500AP(Fri, Jun 14)
- Zoetis Set to Join S&P 500; First Horizon National to Join S&P MidCap 400; QLogic to Join S&P SmallCap 600PR Newswire(Fri, Jun 14)
- Coty Stumbles In Stock Market Debut After Billion-Dollar IPOat Forbes(Thu, Jun 13)
- HD Supply may raise up to $1.3 billion in IPOAP(Thu, Jun 13)
Key Statistics
| Forward P/E (1 yr): | 19.25 |
|---|
| P/S (ttm): | 3.56 |
|---|
| Ex-Dividend Date: | 29-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 1.40 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.36 |
|---|
| Mean Recommendation*: | 2.1 |
|---|
| PEG Ratio (5 yr expected): | 1.45 |
|---|
Business Summary
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines. The company provides livestock products, including vaccines comprising Bovishield line, Improvac/Improvest, RespiSure li...
View More